Brief: Enzychem Lifesciences signs contract worth 81.54 bln won
27/02/2018 03:48
Feb 27(Reuters) - Enzychem Lifesciences Corp 183490.KQ :
* Says it signed 81.54 billion won contract, to provide MRI
contrast medium
Source text in Korean: https://goo.gl/hcM7zD
Further company coverage: 183490.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: Yinglan.Ma.reuters.com@reuters.net))
Recent news on Enzychem Lifesciences
See all newsBrief: Enzychem Lifesciences To Divest 8 Billion Won Worth Of Own Shares
Brief: Enzychem Lifesciences Announces Completion Of Clinical Study Report (Csr) For Phase 2 Study Of Ec-18 In Chemoradiation-Induced Oral Mucositis
South Korea's Enzychem to make Indian drugmaker Cadila's COVID-19 shot (updated)
Brief: Cadila Healthcare Inks Deal With South Korea's Enzychem For Plasmid DNA Vaccine
South Korea's Enzychem to make Indian drugmaker Cadila's COVID-19 shot